¬¿¬Ü¬Ù¬à¬ã¬à¬Þ¬í ¬é¬Ö¬Ý¬à¬Ó¬Ö¬Ü¬Ñ
¬£ ¬Ü¬Ñ¬é¬Ö¬ã¬ä¬Ó¬Ö ¬ã¬í¬â¬î¬ñ, ¬Ü¬à¬ä¬à¬â¬à¬Ö ¬ã¬ä¬Ñ¬Ò¬Ú¬Ý¬Ú¬Ù¬Ú¬â¬å¬Ö¬ä ¬ï¬Ü¬Ù¬à¬ã¬à¬Þ¬í ¬Ó¬í¬ã¬à¬Ü¬à¬Û ¬é¬Ú¬ã¬ä¬à¬ä¬í ¬à¬ä 0,1 ¬Õ¬à 0,5% ¬â¬Ñ¬ã¬ä¬Ó¬à¬â¬Ñ ¬Ü¬å¬Ý¬î¬ä¬å¬â¬í ¬ã¬ä¬Ó¬à¬Ý¬à¬Ó¬í¬ç ¬Ü¬Ý¬Ö¬ä¬à¬Ü ¬ã ¬á¬à¬Þ¬à¬ë¬î¬ð ¬ä¬Ö¬ç¬ß¬à¬Ý¬à¬Ô¬Ú¬Ú ExoBRID,


¬°¬á¬ä¬Ú¬Þ¬Ñ¬Ý¬î¬ß¬Ñ¬ñ ¬ä¬Ö¬ç¬ß¬à¬Ý¬à¬Ô¬Ú¬ñ ¬â¬Ñ¬Ù¬â¬Ñ¬Ò¬à¬ä¬Ü¬Ú ¬Ü¬à¬ã¬Þ¬Ö¬ä¬Ú¬é¬Ö¬ã¬Ü¬Ú¬ç ¬Ú¬ß¬Ô¬â¬Ö¬Õ¬Ú¬Ö¬ß¬ä¬à¬Ó ¬ß¬Ñ ¬à¬ã¬ß¬à¬Ó¬Ö ¬ï¬Ü¬Ù¬à¬ã¬à¬Þ ¬Ò¬Ú¬à¬Ô¬Ú¬Ò¬â¬Ú¬Õ¬ß¬í¬Þ ¬Þ¬Ö¬ä¬à¬Õ¬à¬Þ